Drug Topics Newsletter

To view this email as a web page, click here.

PHARMACISTS' REPORT

Asthma Care Complications

New medications and treatment guidelines

At a Glance: Asthma Biologics

xxxxxx

Obinutuzumab Receives Breakthrough Therapy Designation from FDA

Monoclonal antibody shows potential for lupus nephritis treatment.

Register for NCPA 2019 Annual Convention (Oct. 26-29)

Discover peer-tested solutions designed to invigorate your practice like: “Reinvent Your Pharmacy into a Destination Business” and “Cash Flow, Inventory, and Your Financial Health”.

New GOLD Strategies for COPD Management

Consumer Reports Says Imported Drugs Are "Risky"

An End to the 2019 NYC Measles Outbreak

J.D. Power Releases Pharmacy Survey Results

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.